SweDeliver welcomes Yassir Al-Tikriti, Anton Norberg and David Juriga


SweDeliver's Work Package Parenteral Drug Delivery takes a new important step with the recruitments of Postdoc Yassir Al-Tikriti, PhD Student Anton Norberg and Researcher Dávid Juriga, that join Professor Per Hansson's research environment in Pharmaceutical Physical Chemistry.

Yassir Al-Tikriti, Anton Norberg and David Juriga, SweDeliver
Yassir Al-Tikriti, Anton Norberg and David Juriga, SweDeliver

Yassir Al-Tikriti is already well-known at the Faculty of Pharmacy and SweDeliver, after conducting his PhD project Microgels as drug delivery vehicles: loading and release of amphiphilic drugs, and defending his thesis here June 14, 2022. Yassir Al-Tikriti, a pharmacist with a degree from the University of Baghdad who in 2012 received his Master's degree in Pharmaceutical science at Uppsala University, has for the past year worked as a Pharmaceutical Development & Research Manager at Calliditas Therapeutics AB. We are very happy to once again welcome Yassir, now joining us as Postdoc at the Department of Medicinal Chemistry.

Anton Norberg has previous experience from SweDeliver, as he in the summer of 2021, as one of six very promising students, had the opportunity to do a six-week summer internship at Apotek Produktion & Laboratorier AB – one of the competence center's industrial partners. After graduating from Uppsala University's Master of Science Programme in Pharmacy, Anton has experience from work at Cytiva and Enphasys. We are very happy to welcome Anton as a PhD student in Professor Per Hansson's research group in Pharmaceutical Physical Chemistry, where he will continue the development of Marcus Wanselius' results in the project Physiochemical Aspects of Subcutaneous Administration of Drugs.

Dávid Juriga joins SweDeliver and the Faculty of Pharmacy after having research positions at Semmelweis University and the University of Groningen. At the Department of Medicinal Chemistry, Dávid has already begun his work on studying the relationship between the in vitro properties of different subcutaneously administered peptides – that are promising in cancer therapy – and their bioavailability and absorption in vivo. Important results are to be expected and we are very happy to welcome Dávid to SweDeliver and Uppsala University.


  • SweDeliver’s research in parenteral drug delivery focuses on the development of new formulations and improved delivery systems for subcutaneous drug administration.
  • This research draws on the strong scientific expertise on self-aggregation and molecular interactions within the pharmaceutical physical chemistry group at the Faculty of Pharmacy.



Per HanssonPer Hansson, Professor
Department of Medicinal Chemistry

text: Magnus Alsne, photo: Mikael Wallerstedt, private

More news

Last modified: 2024-04-04